4.7 Review

Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases

Journal

TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 31, Issue 5, Pages 199-205

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2010.01.003

Keywords

-

Funding

  1. NASA [NNJ06HE06A]
  2. NIH [RO1CA128797, R33 CA122864, U54CA143837]
  3. State of Texas, Emerging Technology Fund
  4. Department of Defense (DoD)
  5. [DODW81XWH-09-1-0212]
  6. [DODW81XWH-07-2-0101]
  7. NATIONAL CANCER INSTITUTE [R33CA122864, R01CA128797, U54CA143837] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Nanomedicine is an emerging field that utilizes nano-technology concepts for advanced therapy and diagnostics. This convergent discipline merges research areas such as chemistry, biology, physics, mathematics and engineering. It therefore bridges the gap between molecular and cellular interactions, and has the potential to revolutionize medicine. This review presents recent developments in nanomedicine research poised to have an important impact on the treatment of cardiovascular disease. This will occur through improvement of the diagnosis and therapy of cardiovascular disorders as atherosclerosis, restenosis and myocardial infarction. Specifically, we discuss the use of nanoparticles for molecular imaging and advanced therapeutics, specially designed drug eluting stents and in vivo/ex vivo early detection techniques.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available